Details

September 22-24, 2014

$2,950*

*Includes tuition, books, course materials, parking and most meals.

$3,700*

*Out-of-town price includes 3 nights of accommodations at the Estancia La Jolla Hotel & Spa.

Register

Contact Us

Directions

Testimonials

"This is a great class which provides an excellent overview of key areas of the science behind the biotechnology industry (e.g. cellular and molecular biology and biostatistics) by some of leading experts and researchers in these areas. Fortunately, the material is well tailored for the lay person (nonPhD scientist)--although there is an immense amount in a short time. The course also allows an opportunity to do hands on work with key industry tools like the PCR."

"The course at Rady was very well put together and extremely informative. I found the mix of class instruction and hands on lab experience really helpful in understanding what we were learning. I thought the professors were great and able to clearly communicate technical information to non-technical people."

About the Program

This course, intended for non-scientist business professionals in the Biotech and Pharma industries, provides participants with a practical understanding of the basic science powering their businesses, giving them the essential tools needed to succeed in today's life science industries.This course provides executives and decision makers with a practical understanding of the basic science powering the biotechnology and pharmaceutical industries.

San Diego is one of the nation’s top-ranking biotech centers and is home to more than 500 biotech and four major research institutions. This course is offered through the Rady School of Management in collaboration with UC San Diego’s Division of Biological Sciences and Skaggs School of Pharmacy and Pharmaceutical Sciences.

Focus

  • Science fundamentals
  • Cell biology and molecular biology
  • Stem cell research
  • Personalized medicine and drug delivery
  • Cancer and therapeutic approaches
  • Biosimilars and biobetters
  • Genetic and genome mapping
  • Hands-on lab experience with DNA testing

View the entire list of topics

Who Should Attend

  • CEOs and executives
  • Venture capitalists and angel investors
  • Service providers including attorneys, insurance brokers, real estate professionals
  • Business development executives
  • Consultants
  • Marketing and sales professionals
  • Government officials
  • Executive recruiters
  • Journalists covering related industries

Instructors

Brookie Best, Ph.D.

Dr. Brookie Best is an Associate Professor of Clinical Pharmacy and Pediatrics at the University of California, San Diego (UCSD) Skaggs School of Pharmacy and Pharmaceutical Sciences (SSPPS) and the Department of Pediatrics, School of Medicine (SOM). She completed a Bachelor of Science degree at UCSD in Chemistry with an Emphasis in Chemical Education in 1994. She received her Pharm.D. degree in 1999 from UCSF, and did her residency in Pharmacy Practice at the UCSD Medical Center in 2000. Dr. Best was an NICHD/NIH Fellowship recipient in Pediatric Clinical Pharmacology Research from 2001 to 2004, and completed a Masters of Advanced Studies (M.A.S.) in Clinical Research at UCSD in 2007.

Dr. Best specializes in pharmacokinetics - the processes by which a drug is absorbed, distributed, metabolized and eliminated by the body - and pediatric clinical pharmacology research. Her research efforts have focused on studying anti-HIV drugs in pregnant women, children and non-pregnant adults. She also studies drugs used to treat Kawasaki disease, the leading cause of acquired heart disease in children.

Dr. Best received a Young Investigator award in 2004-2005 to fund research on how genes affect the effectiveness of anti-HIV drugs. She was a National Center for Leadership in Academic Medicine Scholar and co-Valedictorian in 2006, and was honored as a young civic leader by the San Diego Metropolitan Uptown Examiner and Daily Business Report as one of their "Forty Under 40" Honorees. In 2010, she was honored by the SSPPS Class of 2013 as Professor of the Year.

Phil Bourne, Ph.D.

Dr. Phil Bourne is the Associate Director for Data Science (ADDS) at the National Institutes of Health. He is formerly a Professor in the Department of Pharmacology and Skaggs School of Pharmacy and Pharmaceutical Sciences at the University of California San Diego, Associate Director of the RCSB Protein Data Bank and an Adjunct Professor at the Sanford Burnham Institute. He is a past President of the International Society for Computational Biology. He is also an elected fellow of the American Association for the Advancement of Science (AAAS), the International Society for Computational Biology (ISCB) and the American Medical Informatics Association (AMIA). Dr. Bourne has also been recognized as the co-founder and inaugural and current Editor-in-Chief of the open access journal, PLoS Computational Biology, and a long-standing member of the National Science Foundation, National Institutes of Health, and Genome Canada panels, which are responsible for reviewing proposals relating to computational biology.

Dr. Bourne's professional interests focus on relevant biological and educational outcomes derived from computation and scholarly communication. This implies algorithms, text mining, machine learning, metalanguages, biological databases, and visualization applied to problems in drug discovery, evolution, cell signaling, apoptosis, systems biology and scientific dissemination. He has published over 200 papers and 5 books, one of which sold over 150,000 copies. He has co-founded 4 companies: ViSoft Inc., Protein Vision Inc., a company distributing independent films for free and most recently SciVee.

Dr. Bourne Bourne is committed to furthering the free dissemination of science through new models of publishing and better integration and subsequent dissemination of data and results which as far as possible should be freely available to all.

Williams Ettouati, Ph.D.

Dr. Williams Ettouati received his Doctorât d' État en Pharmacie from Université René Descartes, Paris V and a Master of Arts in Biology, University of California, Santa Barbara. He is currently Director, Industry Relations and Development and Health Sciences Associate Clinical Professor at the Skaggs School of Pharmacy and Pharmaceutical Sciences (SSPPS) at the University of California San Diego.

Dr. Ettouati’s role at the Skaggs School of Pharmacy is to develop and secure strategic collaborations, ranging from drug discovery to corporate sponsored fellowships for Pharm.D. students with pharmaceutical and biotechnology companies. Before joining the Skaggs School of Pharmacy and Pharmaceutical Sciences, Dr. Ettouati spent twenty years in the pharmaceutical and biotechnology industry.

Dr. Ettouati served as CEO, President & Co-Founder, Director, GeneProt and Ceptyr early-stage drug discovery biotech companies. In addition, he was Chief Business Officer for several biotech firms such as Hawaii Biotech, responsible for all partnering activities, Vice President Business Development for Syrrx, Aurora/Vertex, Vice President Marketing at DepoTech and product management at Syntex (now Roche), ICI (now Astra-Zeneca). Finally, Dr. Ettouati had an established pharmaceutical consulting practice with many private and public clients.

Larry Goldstein, Ph.D.

Dr. Goldstein received his B.A. degree in biology and genetics from UCSD in 1976 and his Ph.D. degree in genetics from the University of Washington, Seattle in 1980. He did postdoctoral research at the University of Colorado at Boulder from 1980–1983 and the Massachusetts Institute of Technology in 1983/1984. He was Assistant, Associate and Full Professor at Harvard University in the Department of Cellular and Developmental Biology from 1984–1993 and moved to UCSD and HHMI in 1993. His awards include a Senior Scholar Award from the Ellison Medical Foundation, an American Cancer Society Faculty Research Award, and the Loeb Chair in Natural Sciences when he was at Harvard University.

His research is focused on understanding the molecular mechanisms of intracellular movement in neurons and the role of transport failures in neurodegenerative diseases. His lab provided the first molecular descriptions of kinesin structure and organization, and also discovered important links between transport processes and diseases such as Alzheimer's Disease[2] and Huntington's Disease. Dr. Goldstein has also had an active role in National Science policy. He has served on many public science advisory committees, has written about, spoken about, and been interviewed on numerous occasions on science issues by print and broadcast media, and has testified on a number of occasions in the U.S. House of Representatives and the Senate about NIH funding and stem cell research. As a cofounder and consultant of the biotechnology company Cytokinetics, Inc. He has also had an active role in private industry. Goldstein has also served as elected secretary of the American Society for Cell Biology (ASCB).

Randy Hampton, Ph.D.

 

Dr. Randolph Hampton is a Professor of Biochemistry at UC San Diego, Division of Biological Sciences. He received his Ph.D. in Biochemistry at the University of Wisconsin, and did postdoctoral research at UC Berkeley before accepting his current position. His research involves understanding how protein stability is controlled by the cell to allow regulation of normal functions and removal of damaged or misfolded proteins.

Current research in Dr. Hampton’s laboratory focuses on the study of a number of processes that occur in the endoplasmic reticulum, or ER. In the broadest sense, they study how this key organelle manages the quality and quantity of molecules that are part of, or passing through, the ER compartment. Due to its many functions in protein and membrane biogenesis, the ER is important in many aspects of normal cellular functions and aberrations associated with disease. Much of this research involves yeast or mammalian cells.

Stephanie Mel, Ph.D.

Dr. Stephanie Mel received her Ph.D. from the University of California, San Francisco where her work focused on biochemical and biophysical analyses of a bacterial membrane protein. As a Cancer Research Institute post-doctoral fellow at Harvard Medical School she studied Vibrio cholerae, the organism responsible for the disease cholera. Dr. Mel moved to a teaching position in the Division of Biological Sciences at UC San Diego, where she has worked as a Lecturer for the past 16 years.

Dr. Mel has taught a wide variety of both lab and lecture courses in fields including Structural Biochemistry, Molecular Biology, Cell Biology, Physiology, and Genomics and has received several teaching awards. One of Dr. Mel’s main interests has been to introduce research into the undergraduate curriculum at UCSD. Currently, she is working on a DNA barcoding project that gives hundreds of students enrolled in laboratory courses the opportunity to contribute data to a novel research project.

Keefe Reuther, Ph.D.

Keefe Reuther received undergraduate degrees from the University of California Berkeley in Integrative Biology and Geology. This is where he began research in the evolution of social behavior by studying reproductive and aggressive behavior in East African lake cichlid fishes. After taking a year off to pursue research full time, he began his Ph.D. program in ecology, evolution, and systematics at Saint Louis University. His dissertation examined the Japanese pavement ant, an invasive species of ant in the St. Louis, MO metropolitan area. In order to understand the dynamics of an incipient ant invasion, he used methods in behavioral and ecological research as well experiments in computer modeling and population genetics. After graduation he moved to San Diego, where he decided to take his passion for biology and focus on teaching full-time. For the past four years he has been a lecturer at National University, in the San Diego Community College system, and at UCSD where he teaches classes at both the undergraduate and graduate level in general biology, environmental science, evolution, ecology, comparative anatomy, genetics, and molecular biology. When he is not teaching, he enjoys running with his rat terrier and Doberman, competing in triathlons and backpacking.

Jean Y. J. Wang, Ph.D.

Dr. Jean Y. J. Wang received her Ph.D. in Biochemistry from the University of California, Berkeley, where she discovered the first prokaryotic protein kinase and elucidated a protein phosphorylation-regulated metabolic switch between the Krebs cycle and the Glyoxal cycle in the laboratory of Dr. Daniel E. Koshland, Jr. She was a Jane Coffin Childs Postdoctoral Research Fellow at the Massachusetts Institute of Technology Cancer Center where she cloned and characterized the ABL proto-oncogene in the laboratory of Dr. David Baltimore. Dr. Wang joined the faculty at UCSD in 1983 and has risen through the ranks to her current position as a Distinguished Professor in Medicine & Biology, and as the Associate Director of Basic Research at the Moores UCSD Cancer Center.

Dr. Wang's current research is focused on biological mechanisms that regulate the cellular decision to commit suicide in response to genotoxic, inflammatory and detachment stress. Her laboratory employs biochemistry, cell biology, molecular biology, mouse genetic models and high throughput technologies to interrogate the functional links among several cancer genes in the regulation of cell death. In particular, she has focused her research efforts on the ABL tyrosine kinase and the RB tumor suppressor. She is the holder of two patents on the detection and the treatment of CML, which is induced by the oncogenic BCR-ABL kinase.

Location

Located a short distance north of downtown San Diego, La Jolla, CA, is a beachside community that is home to first class dining, entertainment, shopping, sights and attractions. With an average temperature in the 70's, La Jolla sparkles in vacation sunshine year-round.

At Estancia La Jolla Hotel and Spa, they blend charming influences with modern comforts, for a San Diego luxury hotel unlike any other. Feel the warmth within the AAA Four-Diamond Hotel in La Jolla, featuring 10-acres of beautiful rancho-style architecture and lush gardens amid Southern California’s temperate climate.

The 3-story hacienda style hotel in San Diego offers the perfect setting for rest and relaxation. Enjoy the sun-drenched charm and relaxed elegance of Estancia’s La Jolla resort hotel, illuminated with award-winning landscaping of native plants, unique botanical gardens, a heated pool and whirlpool, and plenty of oversized rocking chairs to relax the day away. Estancia guests can also experience complete rejuvenation of mind, body, and soul at their award-winning San Diego hotel spa.

For more information on Estancia La Jolla, visit their website at estancialajolla.com.

Supporting Organizations

ACP-LS